Drug · DIN 02375834 · Veterinary
ONSIOR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 29, 2017; first marketed July 12, 2012.
- Drug Identification Number (DIN)
- 02375834
- Company (DIN owner)
- Elanco Canada LimitedGuelph, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROBENACOXIB | 6 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 29, 2018: NOC 21040Supplement to a New Drug Submission (SNDS) · New indication
- December 22, 2017: NOC 20197Supplement to a New Drug Submission (SNDS) · Additional indications
- March 9, 2016: NOC 17854New Drug Submission (NDS) · Merger - buyout
- December 9, 2013: NOC 15001Supplement to a New Drug Submission (SNDS) · Additional claim
- May 7, 2013: NOC 14341New Drug Submission (NDS) · Admministrative: product name change
- January 12, 2012: NOC 12915Abbreviated New Drug Submission (ANDS) · Change in Brand Name
- November 4, 2011: NOC 12758New Drug Submission (NDS)
Other DINs named ONSIOR
- DIN 02374382 · Marketed
- DIN 02374692 · Marketed
- DIN 02374706 · Marketed
- DIN 02374714 · Marketed
- DIN 02374722 · Marketed